Current Opinion in Lipidology was launched in 1990. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of lipidology is divided into six sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editor for this issue.
Paul N. Durrington
Paul N. Durrington MD FRCP FRCPath FAHA FACP FMed Sci is Professor of Medicine at the University of Manchester, UK and formerly Consultant Physician at Manchester Royal Infirmary, UK. He graduated in physiology and medicine at the University of Bristol, UK and trained in general medicine, diabetes mellitus and metabolic disorders. From 1979–80, he worked at the University of California, San Diego, USA, as a travelling fellow of the British Heart Foundation and American Heart Association. His research interests centre on disorders of lipoprotein metabolism, atherogenic modification of lipoproteins, insulin resistance and diabetes. Dr Durrington was Chairman of the British Hyperlipidaemia Assocation (1992–1995), a member of the British Heart Foundation Project Grants Committee (1997–2000), Director of research and development at the Central Manchester Healthcare Trust (1997–2001), a member of the European Science Foundation Genetics and Epidemiology of Atherosclerosis International Review panel (2005) and leader of the Greater Manchester Vascular Research Network (2008–2012). He is currently a member of the European Cardiac Society Task Force on Dyslipidaemia. In 2001 he was elected to the Fellowship of the Academy of Medical Sciences for his work on diabetic dyslipidaemia and on HDL metabolism. He is author of over 400 original papers and other publications including Hyperlipidaemia: Diagnosis and Management 3rd Edition (2007, London: Hodder Arnold).